Advertisement
Singapore markets open in 7 hours 15 minutes
  • Straits Times Index

    3,303.19
    +10.26 (+0.31%)
     
  • S&P 500

    5,164.00
    +36.21 (+0.71%)
     
  • Dow

    38,799.85
    +124.17 (+0.32%)
     
  • Nasdaq

    16,284.26
    +127.93 (+0.79%)
     
  • Bitcoin USD

    63,004.73
    -1,306.55 (-2.03%)
     
  • CMC Crypto 200

    1,365.26
    +52.63 (+4.01%)
     
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • Gold

    2,332.30
    +23.70 (+1.03%)
     
  • Crude Oil

    78.18
    +0.07 (+0.09%)
     
  • 10-Yr Bond

    4.4890
    -0.0110 (-0.24%)
     
  • Nikkei

    38,236.07
    -38.03 (-0.10%)
     
  • Hang Seng

    18,578.30
    +102.38 (+0.55%)
     
  • FTSE Bursa Malaysia

    1,597.39
    +7.80 (+0.49%)
     
  • Jakarta Composite Index

    7,135.89
    +1.17 (+0.02%)
     
  • PSE Index

    6,652.49
    +36.94 (+0.56%)
     

Dr. Hönle First Quarter 2024 Earnings: €0.15 loss per share (vs €0.26 profit in 1Q 2023)

Dr. Hönle (ETR:HNL) First Quarter 2024 Results

Key Financial Results

  • Revenue: €24.0m (down 13% from 1Q 2023).

  • Net loss: €901.0k (down by 157% from €1.59m profit in 1Q 2023).

  • €0.15 loss per share (down from €0.26 profit in 1Q 2023).

earnings-and-revenue-history
earnings-and-revenue-history

All figures shown in the chart above are for the trailing 12 month (TTM) period

Dr. Hönle Earnings Insights

Looking ahead, revenue is forecast to grow 7.7% p.a. on average during the next 3 years, compared to a 8.1% growth forecast for the Electrical industry in Germany.

Performance of the German Electrical industry.

The company's shares are up 18% from a week ago.

Risk Analysis

Before you take the next step you should know about the 1 warning sign for Dr. Hönle that we have uncovered.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.